Non-HFE hemochromatosis: Genetics, pathogenesis, and clinical management

[1]  A. Pietrangelo,et al.  Non-HFE Hemochromatosis , 2005, Seminars in liver disease.

[2]  T. Ganz,et al.  Hepcidin is decreased in TFR2 hemochromatosis. , 2005, Blood.

[3]  L. Rubbia‐Brandt,et al.  Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene. , 2004, Blood.

[4]  N. Andrews,et al.  Identification of a novel mutation (C321X) in HJV. , 2004, Blood.

[5]  J. Barton,et al.  Hemojuvelin (HJV) mutations in persons of European, African‐American and Asian ancestry with adult onset haemochromatosis , 2004, British journal of haematology.

[6]  X. Jeunemaître,et al.  Juvenile hemochromatosis HJV-related revealed by cardiogenic shock. , 2004, Blood cells, molecules & diseases.

[7]  C. Férec,et al.  The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. , 2004, Human molecular genetics.

[8]  J. Barton,et al.  Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. , 2004, Blood.

[9]  A. Pietrangelo.  Hereditary hemochromatosis--a new look at an old disease. , 2004, The New England journal of medicine.

[10]  T. Frebourg,et al.  Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent , 2004, British journal of haematology.

[11]  M. Cazzola,et al.  Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. , 2004, Blood.

[12]  P. Gow,et al.  A homozygous HAMP mutation in a multiply consanguineous family with pseudo‐dominant juvenile hemochromatosis , 2004, Clinical genetics.

[13]  P. Grammatico,et al.  HAMP gene mutation c.208T>C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis , 2004, Human mutation.

[14]  C. Férec,et al.  HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. , 2004, Blood.

[15]  M. Cazzola,et al.  Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). , 2004, Blood.

[16]  G. Ruggeri,et al.  Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. , 2003, Clinical chemistry.

[17]  R. Kittles,et al.  Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. , 2003, Blood cells, molecules & diseases.

[18]  C. Vulpe,et al.  Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. , 2003, Blood cells, molecules & diseases.

[19]  C. Beaumont,et al.  Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. , 2003, Blood.

[20]  R. Chapman,et al.  Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. , 2003, Human molecular genetics.

[21]  P. Fergelot,et al.  Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. , 2003, Journal of hepatology.

[22]  G. Anderson,et al.  A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient , 2003, Gut.

[23]  P. Gasparini,et al.  Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family. , 2003, Haematologica.

[24]  P. Brissot.  The discovery of the new haemochromatosis gene , 2003 .

[25]  Ai Harashima,et al.  AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[26]  M. Hentze,et al.  Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis , 2003, Nature Genetics.

[27]  N. Andrews,et al.  Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis , 2003, Nature Genetics.

[28]  D. Purdie,et al.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis , 2003, The Lancet.

[29]  A. Bomford.  Genetics of haemochromatosis , 2002, The Lancet.

[30]  M. Loda,et al.  Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. , 2002, Blood.

[31]  M. Cazzola,et al.  Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) , 2002, British journal of haematology.

[32]  V. Felitti,et al.  Penetrance of hemochromatosis. , 2002, Blood cells, molecules & diseases.

[33]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[34]  Andrew T McKie,et al.  Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. , 2002, Gastroenterology.

[35]  M. Marra,et al.  Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. , 2002, Blood.

[36]  W. Hofmann,et al.  Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis. , 2002, Blood.

[37]  W. Sly,et al.  Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Powell,et al.  Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. , 2002, Blood.

[39]  Jennifer J. Pointon,et al.  A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4. , 2002, Blood.

[40]  M. Worwood,et al.  Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). , 2002, Blood.

[41]  M. De Gobbi,et al.  Genetic haemochromatosis: genes and mutations associated with iron loading. , 2002, Best practice & research. Clinical haematology.

[42]  M. Worwood.  HFE Mutations as risk factors in disease. , 2002, Best practice & research. Clinical haematology.

[43]  D. Girelli,et al.  Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. , 2002, Gastroenterology.

[44]  J. Koziol,et al.  Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.

[45]  A. Donovan,et al.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. , 2001, The Journal of clinical investigation.

[46]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Cornelia M. van Duijn,et al.  A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis , 2001, Nature Genetics.

[48]  M. Gobbi,et al.  New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. , 2001, Blood.

[49]  Christina H. Park,et al.  Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.

[50]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[51]  D. Girelli,et al.  Haemochromatosis in patients with β‐thalassaemia trait , 2000, British journal of haematology.

[52]  Peter Schulz-Knappe,et al.  LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.

[53]  Hiroshi Kawabata,et al.  Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in Vivo * , 2000, The Journal of Biological Chemistry.

[54]  Paolo Gasparini,et al.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.

[55]  W. Sly,et al.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Brownlie,et al.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.

[57]  R J Simpson,et al.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.

[58]  H. Koeffler,et al.  Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.

[59]  W. Sly,et al.  HFE gene knockout produces mouse model of hereditary hemochromatosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. McLachlan,et al.  GASTROENTEROLOGY 1998;114:543–549 Distribution of Transferrin Saturation in an Australian Population: Relevance to the Early Diagnosis , 2022 .

[61]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[62]  R. Fauchet,et al.  A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. , 1987, American journal of human genetics.

[63]  R. Fauchet,et al.  [Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen]. , 1975, La Nouvelle presse medicale.

[64]  J. Said,et al.  Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. , 2005, Blood.

[65]  A. Piga,et al.  Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. , 2004, Haematologica.

[66]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[67]  G. Papanikolaou,et al.  Prevalence of the G320V mutation of the HJV gene, associated with juvenile hemochromatosis, in Greece. , 2004, Haematologica.

[68]  A. Pietrangelo.  The ferroportin disease. , 2004, Blood cells, molecules & diseases.

[69]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[70]  Haile Dj.  Assignment of Slc11a3 to mouse chromosome 1 band 1B and SLC11A3 to human chromosome 2q32 by in situ hybridization. , 2000 .